REPORT ID 3437

Asia-Pacific Escitalopram Market Report 2017

Publish Date
13-Dec-17
Pages
111
Format
Electronic (PDF)

In this report, the Asia-Pacific Escitalopram market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Escitalopram for these regions, from 2012 to 2022 (forecast), including
    China
    Japan
    South Korea
    Taiwan
    India
    Southeast Asia
    Australia

Asia-Pacific Escitalopram market competition by top manufacturers/players, with Escitalopram sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Forest Laboratories(US)
    H.Lundbeck A/S(DK)
    Amneal Pharmaceuticals(US)
    Aurobindo Pharma(IN)
    Hetero Drugs(IN)
    Macleods Pharmaceuticals(IN)
    Silarx Pharmacueticals(US)
    Apotex(CA)
    Hikma Pharmaceuticals(UK)
    Jubilant Pharma(SG)
    Lupin Limited(IN)
    Prinston Pharmaceutical(US)
    STI Pharma(US)
    TEVA Pharmaceutical(US)

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
    Solution
    Tablet
    Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Escitalopram for each application, includin
    Hospitals and Clinics
    Individual Use
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Asia-Pacific Escitalopram Market Report 2017
1 Escitalopram Overview
    1.1 Product Overview and Scope of Escitalopram
    1.2 Classification of Escitalopram by Product Category
        1.2.1 Asia-Pacific Escitalopram Market Size (Sales) Comparison by Types (2012-2022)
        1.2.2 Asia-Pacific Escitalopram Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Solution
        1.2.4 Tablet
        1.2.5 Others
    1.3 Asia-Pacific Escitalopram Market by Application/End Users
        1.3.1 Asia-Pacific Escitalopram Sales (Volume) and Market Share Comparison by Applications (2012-2022)
        1.3.2 Hospitals and Clinics
        1.3.3 Individual Use
        1.3.4 Others
    1.4 Asia-Pacific Escitalopram Market by Region
        1.4.1 Asia-Pacific Escitalopram Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 China Status and Prospect (2012-2022)
        1.4.3 Japan Status and Prospect (2012-2022)
        1.4.4 South Korea Status and Prospect (2012-2022)
        1.4.5 Taiwan Status and Prospect (2012-2022)
        1.4.6 India Status and Prospect (2012-2022)
        1.4.7 Southeast Asia Status and Prospect (2012-2022)
        1.4.8 Australia Status and Prospect (2012-2022)
    1.5 Asia-Pacific Market Size (Value and Volume) of Escitalopram (2012-2022)
        1.5.1 Asia-Pacific Escitalopram Sales and Growth Rate (2012-2022)
        1.5.2 Asia-Pacific Escitalopram Revenue and Growth Rate (2012-2022)

2 Asia-Pacific Escitalopram Competition by Players/Suppliers, Region, Type and Application
    2.1 Asia-Pacific Escitalopram Market Competition by Players/Suppliers
        2.1.1 Asia-Pacific Escitalopram Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
        2.1.2 Asia-Pacific Escitalopram Revenue and Share by Players/Suppliers (2012-2017)
    2.2 Asia-Pacific Escitalopram (Volume and Value) by Type
        2.2.1 Asia-Pacific Escitalopram Sales and Market Share by Type (2012-2017)
        2.2.2 Asia-Pacific Escitalopram Revenue and Market Share by Type (2012-2017)
    2.3 Asia-Pacific Escitalopram (Volume) by Application
    2.4 Asia-Pacific Escitalopram (Volume and Value) by Region
        2.4.1 Asia-Pacific Escitalopram Sales and Market Share by Region (2012-2017)
        2.4.2 Asia-Pacific Escitalopram Revenue and Market Share by Region (2012-2017)

3 China Escitalopram (Volume, Value and Sales Price)
    3.1 China Escitalopram Sales and Value (2012-2017)
        3.1.1 China Escitalopram Sales Volume and Growth Rate (2012-2017)
        3.1.2 China Escitalopram Revenue and Growth Rate (2012-2017)
        3.1.3 China Escitalopram Sales Price Trend (2012-2017)
    3.2 China Escitalopram Sales Volume and Market Share by Type
    3.3 China Escitalopram Sales Volume and Market Share by Application

4 Japan Escitalopram (Volume, Value and Sales Price)
    4.1 Japan Escitalopram Sales and Value (2012-2017)
        4.1.1 Japan Escitalopram Sales Volume and Growth Rate (2012-2017)
        4.1.2 Japan Escitalopram Revenue and Growth Rate (2012-2017)
        4.1.3 Japan Escitalopram Sales Price Trend (2012-2017)
    4.2 Japan Escitalopram Sales Volume and Market Share by Type
    4.3 Japan Escitalopram Sales Volume and Market Share by Application

5 South Korea Escitalopram (Volume, Value and Sales Price)
    5.1 South Korea Escitalopram Sales and Value (2012-2017)
        5.1.1 South Korea Escitalopram Sales Volume and Growth Rate (2012-2017)
        5.1.2 South Korea Escitalopram Revenue and Growth Rate (2012-2017)
        5.1.3 South Korea Escitalopram Sales Price Trend (2012-2017)
    5.2 South Korea Escitalopram Sales Volume and Market Share by Type
    5.3 South Korea Escitalopram Sales Volume and Market Share by Application

6 Taiwan Escitalopram (Volume, Value and Sales Price)
    6.1 Taiwan Escitalopram Sales and Value (2012-2017)
        6.1.1 Taiwan Escitalopram Sales Volume and Growth Rate (2012-2017)
        6.1.2 Taiwan Escitalopram Revenue and Growth Rate (2012-2017)
        6.1.3 Taiwan Escitalopram Sales Price Trend (2012-2017)
    6.2 Taiwan Escitalopram Sales Volume and Market Share by Type
    6.3 Taiwan Escitalopram Sales Volume and Market Share by Application

7 India Escitalopram (Volume, Value and Sales Price)
    7.1 India Escitalopram Sales and Value (2012-2017)
        7.1.1 India Escitalopram Sales Volume and Growth Rate (2012-2017)
        7.1.2 India Escitalopram Revenue and Growth Rate (2012-2017)
        7.1.3 India Escitalopram Sales Price Trend (2012-2017)
    7.2 India Escitalopram Sales Volume and Market Share by Type
    7.3 India Escitalopram Sales Volume and Market Share by Application

8 Southeast Asia Escitalopram (Volume, Value and Sales Price)
    8.1 Southeast Asia Escitalopram Sales and Value (2012-2017)
        8.1.1 Southeast Asia Escitalopram Sales Volume and Growth Rate (2012-2017)
        8.1.2 Southeast Asia Escitalopram Revenue and Growth Rate (2012-2017)
        8.1.3 Southeast Asia Escitalopram Sales Price Trend (2012-2017)
    8.2 Southeast Asia Escitalopram Sales Volume and Market Share by Type
    8.3 Southeast Asia Escitalopram Sales Volume and Market Share by Application

9 Australia Escitalopram (Volume, Value and Sales Price)
    9.1 Australia Escitalopram Sales and Value (2012-2017)
        9.1.1 Australia Escitalopram Sales Volume and Growth Rate (2012-2017)
        9.1.2 Australia Escitalopram Revenue and Growth Rate (2012-2017)
        9.1.3 Australia Escitalopram Sales Price Trend (2012-2017)
    9.2 Australia Escitalopram Sales Volume and Market Share by Type
    9.3 Australia Escitalopram Sales Volume and Market Share by Application

10 Asia-Pacific Escitalopram Players/Suppliers Profiles and Sales Data
    10.1 Forest Laboratories(US)
        10.1.1 Company Basic Information, Manufacturing Base and Competitors
        10.1.2 Escitalopram Product Category, Application and Specification
            10.1.2.1 Product A
            10.1.2.2 Product B
        10.1.3 Forest Laboratories(US) Escitalopram Sales, Revenue, Price and Gross Margin (2012-2017)
        10.1.4 Main Business/Business Overview
    10.2 H.Lundbeck A/S(DK)
        10.2.1 Company Basic Information, Manufacturing Base and Competitors
        10.2.2 Escitalopram Product Category, Application and Specification
            10.2.2.1 Product A
            10.2.2.2 Product B
        10.2.3 H.Lundbeck A/S(DK) Escitalopram Sales, Revenue, Price and Gross Margin (2012-2017)
        10.2.4 Main Business/Business Overview
    10.3 Amneal Pharmaceuticals(US)
        10.3.1 Company Basic Information, Manufacturing Base and Competitors
        10.3.2 Escitalopram Product Category, Application and Specification
            10.3.2.1 Product A
            10.3.2.2 Product B
        10.3.3 Amneal Pharmaceuticals(US) Escitalopram Sales, Revenue, Price and Gross Margin (2012-2017)
        10.3.4 Main Business/Business Overview
    10.4 Aurobindo Pharma(IN)
        10.4.1 Company Basic Information, Manufacturing Base and Competitors
        10.4.2 Escitalopram Product Category, Application and Specification
            10.4.2.1 Product A
            10.4.2.2 Product B
        10.4.3 Aurobindo Pharma(IN) Escitalopram Sales, Revenue, Price and Gross Margin (2012-2017)
        10.4.4 Main Business/Business Overview
    10.5 Hetero Drugs(IN)
        10.5.1 Company Basic Information, Manufacturing Base and Competitors
        10.5.2 Escitalopram Product Category, Application and Specification
            10.5.2.1 Product A
            10.5.2.2 Product B
        10.5.3 Hetero Drugs(IN) Escitalopram Sales, Revenue, Price and Gross Margin (2012-2017)
        10.5.4 Main Business/Business Overview
    10.6 Macleods Pharmaceuticals(IN)
        10.6.1 Company Basic Information, Manufacturing Base and Competitors
        10.6.2 Escitalopram Product Category, Application and Specification
            10.6.2.1 Product A
            10.6.2.2 Product B
        10.6.3 Macleods Pharmaceuticals(IN) Escitalopram Sales, Revenue, Price and Gross Margin (2012-2017)
        10.6.4 Main Business/Business Overview
    10.7 Silarx Pharmacueticals(US)
        10.7.1 Company Basic Information, Manufacturing Base and Competitors
        10.7.2 Escitalopram Product Category, Application and Specification
            10.7.2.1 Product A
            10.7.2.2 Product B
        10.7.3 Silarx Pharmacueticals(US) Escitalopram Sales, Revenue, Price and Gross Margin (2012-2017)
        10.7.4 Main Business/Business Overview
    10.8 Apotex(CA)
        10.8.1 Company Basic Information, Manufacturing Base and Competitors
        10.8.2 Escitalopram Product Category, Application and Specification
            10.8.2.1 Product A
            10.8.2.2 Product B
        10.8.3 Apotex(CA) Escitalopram Sales, Revenue, Price and Gross Margin (2012-2017)
        10.8.4 Main Business/Business Overview
    10.9 Hikma Pharmaceuticals(UK)
        10.9.1 Company Basic Information, Manufacturing Base and Competitors
        10.9.2 Escitalopram Product Category, Application and Specification
            10.9.2.1 Product A
            10.9.2.2 Product B
        10.9.3 Hikma Pharmaceuticals(UK) Escitalopram Sales, Revenue, Price and Gross Margin (2012-2017)
        10.9.4 Main Business/Business Overview
    10.10 Jubilant Pharma(SG)
        10.10.1 Company Basic Information, Manufacturing Base and Competitors
        10.10.2 Escitalopram Product Category, Application and Specification
            10.10.2.1 Product A
            10.10.2.2 Product B
        10.10.3 Jubilant Pharma(SG) Escitalopram Sales, Revenue, Price and Gross Margin (2012-2017)
        10.10.4 Main Business/Business Overview
    10.11 Lupin Limited(IN)
    10.12 Prinston Pharmaceutical(US)
    10.13 STI Pharma(US)
    10.14 TEVA Pharmaceutical(US)

11 Escitalopram Manufacturing Cost Analysis
    11.1 Escitalopram Key Raw Materials Analysis
        11.1.1 Key Raw Materials
        11.1.2 Price Trend of Key Raw Materials
        11.1.3 Key Suppliers of Raw Materials
        11.1.4 Market Concentration Rate of Raw Materials
    11.2 Proportion of Manufacturing Cost Structure
        11.2.1 Raw Materials
        11.2.2 Labor Cost
        11.2.3 Manufacturing Expenses
    11.3 Manufacturing Process Analysis of Escitalopram

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
    12.1 Escitalopram Industrial Chain Analysis
    12.2 Upstream Raw Materials Sourcing
    12.3 Raw Materials Sources of Escitalopram Major Manufacturers in 2016
    12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
    13.1 Marketing Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
        13.1.3 Marketing Channel Development Trend
    13.2 Market Positioning
        13.2.1 Pricing Strategy
        13.2.2 Brand Strategy
        13.2.3 Target Client
    13.3 Distributors/Traders List

14 Market Effect Factors Analysis
    14.1 Technology Progress/Risk
        14.1.1 Substitutes Threat
        14.1.2 Technology Progress in Related Industry
    14.2 Consumer Needs/Customer Preference Change
    14.3 Economic/Political Environmental Change

15 Asia-Pacific Escitalopram Market Forecast (2017-2022)
    15.1 Asia-Pacific Escitalopram Sales Volume, Revenue and Price Forecast (2017-2022)
        15.1.1 Asia-Pacific Escitalopram Sales Volume and Growth Rate Forecast (2017-2022)
        15.1.2 Asia-Pacific Escitalopram Revenue and Growth Rate Forecast (2017-2022)
        15.1.3 Asia-Pacific Escitalopram Price and Trend Forecast (2017-2022)
    15.2 Asia-Pacific Escitalopram Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
        15.2.1 Asia-Pacific Escitalopram Sales Volume and Growth Rate Forecast by Region (2017-2022)
        15.2.2 Asia-Pacific Escitalopram Revenue and Growth Rate Forecast by Region (2017-2022)
        15.2.3 China Escitalopram Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.4 Japan Escitalopram Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.5 South Korea Escitalopram Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.6 Taiwan Escitalopram Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.7 India Escitalopram Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.8 Southeast Asia Escitalopram Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.9 Australia Escitalopram Sales, Revenue and Growth Rate Forecast (2017-2022)
    15.3 Asia-Pacific Escitalopram Sales, Revenue and Price Forecast by Type (2017-2022)
        15.3.1 Asia-Pacific Escitalopram Sales Forecast by Type (2017-2022)
        15.3.2 Asia-Pacific Escitalopram Revenue Forecast by Type (2017-2022)
        15.3.3 Asia-Pacific Escitalopram Price Forecast by Type (2017-2022)
    15.4 Asia-Pacific Escitalopram Sales Forecast by Application (2017-2022)

16 Research Findings and Conclusion

17 Appendix
    17.1 Methodology/Research Approach
        17.1.1 Research Programs/Design
        17.1.2 Market Size Estimation
        17.1.3 Market Breakdown and Data Triangulation
    17.2 Data Source
        17.2.1 Secondary Sources
        17.2.2 Primary Sources
    17.3 Disclaimer